Hims jumps as RFK Jr. Seeks to loosen peptide regulations.

{
  "signal_id": "661c9543-54c7-4523-9c20-ad36cd96df84",
  "signal_type": "news",
  "signal_subtype": "expands_facilities",
  "detected_at": "2026-04-16T00:00:00+00:00",
  "company": {
    "name": "Hims & Hers",
    "domain": "hims.com"
  },
  "data": {
    "url": "https://www.businessoffashion.com/news/beauty/hims-jumps-peptide-regulations-rfk-jr",
    "title": "Hims jumps as RFK Jr. Seeks to loosen peptide regulations.",
    "excerpt": "Hims jumps as RFK Jr. Seeks to loosen peptide regulations.\n\nHims & Hers Health Inc. surged as much as 12 percent after Health Secretary Robert F. Kennedy Jr. said US drug regulators will loosen restrictions around a dozen popular peptide injections.\n\n16 April 2026\n\nHims & Hers Health Inc. surged as much as 12 percent after Health Secretary Robert F. Kennedy Jr. said US drug regulators will loosen restrictions around a dozen popular peptide injections.\n\n\"Today, we took long-overdue action to restore science, accountability, and the rule of law,\" Kennedy said Wednesday in an X post. \"This action begins to restore regulated access and will immediately begin shifting demand away from the black market.\"\n\nKennedy said that the US Food and Drug Administration will take steps to allow certain peptides to be made by compounding pharmacies, potentially overturning a Biden-era ruling that had determined there were too many safety risks for them to be widely manufactured and sold.\n\nThe FDA will convene a group of independent experts in July to discuss the evidence behind certain peptides, according to a notice posted earlier on Wednesday. Called an advisory committee meeting, the move usually precedes decisive action around new drugs or medical devices.\n\nThat could bode well for companies like Hims, which have signalled plans to sell peptides once regulations are loosened. Currently, with...",
    "summary": "Hims, Inc. expanded facilities to California, United States, Northern America, Americas on Jul 1st '25.",
    "category": "expands_facilities",
    "found_at": "2026-04-16T00:00:00Z",
    "location": "California, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://img.businessoffashion.com/resizer/v2/NBRMOE4VHVDXDEGHSJYBR5ARQA.jpg?smart=true&auth=0c0fe91acb37244e15d7b835ba193f81e892400a253605bdcb1b72647d3b05d4&width=1200&height=630",
    "confidence": 0.5354,
    "published_at": "2026-04-16T00:00:00Z",
    "location_data": [
      {
        "state": "California",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2025-07-01",
    "article_sentence": "Hims bought a peptide manufacturing facility in California in 2025 for an undisclosed amount."
  }
}

curl https://signals.autobound.ai/v1/signals/661c9543-54c7-4523-9c20-ad36cd96df84 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"hims.com","limit":20}'